metricas
covid
Medicina Clínica (English Edition) Factor XI inhibitors: A new era in antithrombotic therapy
Journal Information
Vol. 162. Issue 2.
Pages 73-76 (January 2024)
Vol. 162. Issue 2.
Pages 73-76 (January 2024)
Special article
Factor XI inhibitors: A new era in antithrombotic therapy
Inhibidores del factor XI: una nueva era en el tratamiento antitrombótico
José A. Páramo
Corresponding author
japaramo@unav.es

Corresponding author.
, Maria Marcos-Jubilar
Servicio de Hematología y Hemoterapia, Clínica Universidad de Navarra, Pamplona, Spain
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (4)
Table 1. Mechanism of action of factor XI inhibitors.
Tables
Table 2. Classification and characteristics of factor XI inhibitors.
Tables
Table 3. Comparison of pharmacological characteristics of DOACs – direct thrombin inhibitors, factor Xa inhibitors, and oral direct factor XIa inhibitors.
Tables
Table 4. Ongoing phase 3 clinical studies with factor XI inhibitors.
Tables
Show moreShow less

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools